Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure

NCT04049045 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Decompensated Heart Failure

Interventions

DRUG: Empagliflozin 25 mg
DRUG: Placebo

Sponsor

Christian Schulze

Collaborators

[object Object]
[object Object]